🇺🇸 cyanoacrylate in United States

76 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Off Label Use — 23 reports (30.26%)
  2. Product Use In Unapproved Indication — 14 reports (18.42%)
  3. Product Use Issue — 11 reports (14.47%)
  4. Cerebral Infarction — 6 reports (7.89%)
  5. Candida Infection — 5 reports (6.58%)
  6. Drug Ineffective For Unapproved Indication — 4 reports (5.26%)
  7. Haemorrhage — 4 reports (5.26%)
  8. Liver Abscess — 3 reports (3.95%)
  9. Sepsis — 3 reports (3.95%)
  10. Ulcer — 3 reports (3.95%)

Source database →

cyanoacrylate in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Other approved in United States

Frequently asked questions

Is cyanoacrylate approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for cyanoacrylate in United States?

Kaohsiung Veterans General Hospital. is the originator. The local marketing authorisation holder may differ — check the official source linked above.